Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose ATRA in PSC
NCT03359174Phase 2Terminated
- Sponsor
- Yale University
- Start
- May 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin in Primary Sclerosing Cholangitis (PSC), sponsored by Yale University. Started May 2018; status: terminated.
02
Drugs
tretinoin
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT03359174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03359174.